1979
DOI: 10.1111/j.1600-0536.1979.tb04908.x
|View full text |Cite
|
Sign up to set email alerts
|

Human cutaneous vulvar reactivity to irritants

Abstract: To better understand the cutaneous reactivity of vulvar skin, two chemical irritants were applied topically to 21 subjects. The forearm of each subject served as a comparative control. Test sites remained open and were read at 24 hours. A significantly increased response to the irritants was noted on the vulvar skin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
35
0
2

Year Published

2000
2000
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 101 publications
(38 citation statements)
references
References 3 publications
1
35
0
2
Order By: Relevance
“…Britz and Maibach [8] used two irritants, benzalkonium chloride (17%) and maleic acid (20%), for their ability to induce erythema without gross destruction of skin. These chemicals were applied at the labia majora and ventral forearm unoccluded.…”
Section: Irritant Reactivity Of Vulvar Skinmentioning
confidence: 99%
“…Britz and Maibach [8] used two irritants, benzalkonium chloride (17%) and maleic acid (20%), for their ability to induce erythema without gross destruction of skin. These chemicals were applied at the labia majora and ventral forearm unoccluded.…”
Section: Irritant Reactivity Of Vulvar Skinmentioning
confidence: 99%
“…the forearm) is not predictive for the objective assessment of irritant dermatitis of the vulva, we sought to establish a standard procedure for assessing vulvar skin TEWL [11][12][13]. In this way, TEWL could be used as an indicator for the integrity and clinical status of vulvar skin.…”
Section: Introductionmentioning
confidence: 99%
“…Vulval skin has been shown to be more liable to the adverse effects of irritants compared with skin elsewhere [6,7]. In those studies addressing contact allergy affecting the vulva there have been wide variations in the proportions of patients with relevant allergic reactions ranging from 19 to 58% [3,4,8,9].…”
Section: Discussionmentioning
confidence: 99%